Podcast Journal Club

The Benefits of Tirzepatide in Hispanic/Latino Individuals

March 21, 2024

EFL047

Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Alyson K. Myers, MD, from Albert Einstein College of Medicine and guest expert Leonor Corsino, MD, from Duke University School of Medicine. The article featured this month, by Frías et al, was published in the February 2024 issue of JCEM: “Tirzepatide in Hispanic/Latino Patients With Type 2 Diabetes: A Subgroup Analysis of the SURPASS Program.”

Meet the Speakers

Leonor Corsino and Alyson Myers

Leonor Corsino, MD, is an associate professor in the Departments of Medicine (Tenure), Division of Endocrinology, Metabolism and Nutrition, and Population Health Sciences. She is an adult endocrinologist. Dr. Corsino’s research focuses on diabetes, obesity, and related complications and health disparities, with a particular interest in Hispanic/Latino populations. She has successfully led and extensively collaborated with investigators locally, nationally, and internationally. She has broad experience in research, with previous work in basic science, clinical, translational, health service, epidemiologic, and community engagement research. She has been the PI and co-investigator on several foundation, internal, industry, and NIH-funded grants. Her research and contribution have been recognized locally and nationally with many awards. Dr Corsino is the author of more than 60 peer review publications, editor of one book, and author of 4 book chapters. Dr. Corsino practices general endocrinology at Duke University.

Alyson Myers, MD, is an associate professor and the Associate Chair for Diversity, Equity, and Inclusion for the Department of Medicine at Montefiore/Albert Einstein in the Bronx, N.Y. She also is an adjunct associate professor at the Zucker School of Medicine at Hofstra/Northwell, where she also served as the medical director of inpatient diabetes for North Shore University Hospital from 2013–2021. Dr. Myers attended the University of Virginia, where she majored in French and minored in chemistry. After college, she returned home to Queens, N.Y., to teach junior high school math and science. A year later, she attended SUNY Downstate for medical school, where she was the four-year recipient of the President’s Award Scholarship. She completed a five-year combined internal medicine/psychiatry residency at Rush University Medical Center in Chicago. During her fourth year, she was chief resident. After residency, she completed an endocrinology fellowship at the University of Texas Southwestern. During fellowship, she received a T32 training grant in mood disorders and diabetes under the mentorship of Madhukar Trivedi, MD. In 2022, Dr. Myers was co-awarded a Center for Diabetes Translational Research grant to further examine and improve the health outcomes of persons with diabetic foot ulcers. Her goal is to lower the high rate of amputations of Black and Brown persons with diabetes in the Bronx by using multidisciplinary care and limb salvage techniques. Dr. Myers has several publications on the topics of diabetes disparities and diabetes technology. She has been a long-time reviewer for several journals, including: Journal of Immigrant and Minority Health, Journal of Diabetes Science and Technology, and Diabetes Care. In 2023, she was the editor of Diabetes and COVID-19: Considerations and Clinical Management. Also, she is an active member of the Endocrine Society as an abstract reviewer, member of the Publications Core Committee, and a co-lead for the ExCEL Program, which provides leadership training for endocrine fellows and early career attendings. Dr. Myers has served two terms on the American Board of Endocrinology, Diabetes, & Metabolism.

Resources


Subscribe

Stay up to date by copying this link into your podcast player or:

Apple Podcasts
Spotify

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.